CVRx, Inc.

CVRX Nasdaq CIK: 0001235912

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 9201 WEST BROADWAY AVENUE, MINNEAPOLIS, MN, 55445
Mailing Address 9201 WEST BROADWAY AVENUE, MINNEAPOLIS, MN, 55445
Phone 7634162850
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report March 16, 2026 View on SEC
3 Initial insider ownership report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
8-K Current report of material events March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
4 Insider stock transaction report February 23, 2026 View on SEC

Annual Reports

10-K February 13, 2026
  • Barostim, the flagship product, has U.S. FDA Breakthrough Device designation and full FDA approval for heart failure patients.
  • Achieved significant revenue growth of 67% to $50.3 million in FY2025, primarily driven by increased Barostim adoption in the U.S. market.
View Analysis

Insider Trading

BUY 6 insiders 7 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.